Intelligent Ultrasound Group plc, through its subsidiaries, develops, markets, and distributes medical training simulators in the United Kingdom, North America, and internationally. More Details
Flawless balance sheet and overvalued.
Share Price & News
How has Intelligent Ultrasound Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: IUG is not significantly more volatile than the rest of UK stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: IUG's weekly volatility (7%) has been stable over the past year.
7 Day Return
GB Healthcare Services
1 Year Return
GB Healthcare Services
Return vs Industry: IUG underperformed the UK Healthcare Services industry which returned 75.8% over the past year.
Return vs Market: IUG exceeded the UK Market which returned 26.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Intelligent Ultrasound Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 month ago | Simply Wall StCompanies Like Intelligent Ultrasound Group (LON:IUG) Are In A Position To Invest In Growth
3 months ago | Simply Wall StIntelligent Ultrasound Group (LON:IUG) Share Prices Have Dropped 70% In The Last Five Years
5 months ago | Simply Wall StWe're Not Very Worried About Intelligent Ultrasound Group's (LON:MED) Cash Burn Rate
Is Intelligent Ultrasound Group undervalued compared to its fair value and its price relative to the market?
Price to Book (PB) ratio
Share Price vs. Fair Value
Below Fair Value: Insufficient data to calculate IUG's fair value to establish if it is undervalued.
Significantly Below Fair Value: Insufficient data to calculate IUG's fair value to establish if it is undervalued.
Price To Earnings Ratio
PE vs Industry: IUG is unprofitable, so we can't compare its PE Ratio to the XE Healthcare Services industry average.
PE vs Market: IUG is unprofitable, so we can't compare its PE Ratio to the UK market.
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate IUG's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: IUG is good value based on its PB Ratio (3.9x) compared to the GB Healthcare Services industry average (6.6x).
How is Intelligent Ultrasound Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Intelligent Ultrasound Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
How has Intelligent Ultrasound Group performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: IUG is currently unprofitable.
Growing Profit Margin: IUG is currently unprofitable.
Past Earnings Growth Analysis
Earnings Trend: IUG is unprofitable, and losses have increased over the past 5 years at a rate of 12.4% per year.
Accelerating Growth: Unable to compare IUG's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: IUG is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (8.6%).
Return on Equity
High ROE: IUG has a negative Return on Equity (-26.05%), as it is currently unprofitable.
How is Intelligent Ultrasound Group's financial position?
Financial Position Analysis
Short Term Liabilities: IUG's short term assets (£12.5M) exceed its short term liabilities (£2.2M).
Long Term Liabilities: IUG's short term assets (£12.5M) exceed its long term liabilities (£943.0K).
Debt to Equity History and Analysis
Debt Level: IUG is debt free.
Reducing Debt: IUG had no debt 5 years ago.
Cash Runway Analysis
For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: IUG has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: IUG has sufficient cash runway for 2.7 years if free cash flow continues to reduce at historical rates of 14.9% each year.
What is Intelligent Ultrasound Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate IUG's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate IUG's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if IUG's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IUG's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IUG's dividend in 3 years as they are not forecast to pay a notable one for the UK market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Stuart Gall (57 yo)
Mr. Stuart A. Gall serves as Commercial Director of Fusion IP plc. Mr. Gall serves as the Chief Executive Officer of Demasq Limited. He has been Chief Executive Officer of Intelligent Ultrasound Group plc ...
CEO Compensation Analysis
Compensation vs Market: Stuart's total compensation ($USD343.65K) is about average for companies of similar size in the UK market ($USD338.50K).
Compensation vs Earnings: Stuart's compensation has been consistent with company performance over the past year.
Experienced Management: IUG's management team is considered experienced (2.3 years average tenure).
Experienced Board: IUG's board of directors are considered experienced (8.2 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Intelligent Ultrasound Group plc's company bio, employee growth, exchange listings and data sources
- Name: Intelligent Ultrasound Group plc
- Ticker: IUG
- Exchange: AIM
- Founded: 2004
- Industry: Health Care Technology
- Sector: Healthcare
- Market Cap: UK£49.838m
- Shares outstanding: 269.40m
- Website: https://www.intelligentultrasound.com
Number of Employees
- Intelligent Ultrasound Group plc
- Hodge House
- Floor 6A
- South Glamorgan
- CF10 1DY
- United Kingdom
Intelligent Ultrasound Group plc, through its subsidiaries, develops, markets, and distributes medical training simulators in the United Kingdom, North America, and internationally. It also develops clinic...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/05/09 18:33|
|End of Day Share Price||2021/05/07 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.